Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.7196
-0.0125 (-1.71%)
Jun 3, 2026, 11:49 AM EDT - Market open
Trinity Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.14 | 5.17 | 3.69 | 6.58 | 25.91 |
Cash & Short-Term Investments | 5.14 | 5.17 | 3.69 | 6.58 | 25.91 |
Cash Growth | -0.56% | 39.99% | -43.89% | -74.61% | -5.18% |
Accounts Receivable | 11.48 | 16.07 | 13.9 | 15.75 | 16.12 |
Other Receivables | 0.46 | 0.52 | 1.52 | 1.83 | 1.54 |
Total Trade Receivables | 11.94 | 16.58 | 15.42 | 17.59 | 17.66 |
Inventory | 18.83 | 19.37 | 19.93 | 22.5 | 29.12 |
Total Current Assets | 35.9 | 41.12 | 39.04 | 46.67 | 72.69 |
Net Property, Plant & Equipment | 5.3 | 4.62 | 1.89 | 5.68 | 5.92 |
Goodwill | 56.99 | 51.34 | 16.27 | 35.27 | 35.98 |
Long-Term Investments | 2.77 | 2.46 | - | - | - |
Other Long-Term Assets | 4.2 | 3.75 | 2.23 | 4.49 | 4.31 |
Total Assets | 105.17 | 103.29 | 59.44 | 92.1 | 118.9 |
Accounts Payable | 29.7 | 26.78 | 12.8 | 15.38 | 15.13 |
Current Portion of Long-Term Debt | 108.02 | - | - | - | - |
Current Portion of Leases | 2.59 | 2.29 | 1.69 | 1.68 | 1.98 |
Other Current Liabilities | 0.69 | 2.82 | 0.33 | 0.08 | 0.07 |
Total Current Liabilities | 141.21 | 32.1 | 15.04 | 17.34 | 100.49 |
Long-Term Debt | 16.54 | 88 | 54.86 | 58.26 | 83.31 |
Long-Term Leases | 10.84 | 10.48 | 10.87 | 12.27 | 13.87 |
Other Long-Term Liabilities | 8.77 | 8.11 | 2.83 | 6.63 | 4.86 |
Total Long-Term Liabilities | 35.94 | 106.38 | 68.35 | 76.94 | 18.72 |
Total Liabilities | 177.15 | 138.47 | 83.38 | 94.28 | 119.21 |
Common Stock | 0.04 | 4.19 | 1.97 | 1.96 | 1.21 |
Treasury Stock | -24.92 | -24.92 | -24.92 | -24.92 | -24.92 |
Additional Paid-in Capital | 70.51 | 70.11 | 53.33 | 53.17 | 16.19 |
Accumulated Other Comprehensive Income | -1.44 | -5.44 | -5.68 | -5.69 | -5.36 |
Retained Earnings | -116.17 | -79.12 | -48.64 | -26.7 | 12.56 |
Shareholders' Equity | -71.98 | -35.18 | -23.95 | -2.18 | -0.32 |
Total Liabilities & Equity | 105.17 | 103.29 | 59.44 | 92.1 | 118.9 |
Total Debt | 137.98 | 100.76 | 67.43 | 72.2 | 99.16 |
Net Cash (Debt) | -132.85 | -95.6 | -63.74 | -65.62 | -73.25 |
Net Cash Per Share | -7.15 | -5.32 | -8.33 | -9.73 | -17.52 |
Book Value | -71.98 | -35.18 | -23.95 | -2.18 | -0.32 |
Book Value Per Share | -3.88 | -1.96 | -3.13 | -0.32 | -0.08 |
Tangible Book Value | -128.97 | -86.52 | -40.22 | -37.45 | -36.3 |
Tangible Book Value Per Share | -6.94 | -4.82 | -5.25 | -5.55 | -8.68 |